一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
WhatsApp
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >MI-538
MI-538
  • MI-538

MI-538 NEW

Price $58 $118 $198
Package 1mg 5mg 10mg
Supply Ability: 10g
Update Time: 2026-07-14

Product Details

Product Name: MI-538 CAS No.: 1857417-10-7
Purity: 99.80% Supply Ability: 10g
Release date: 2026/07/14

Product Introduction

Bioactivity

NameMI-538
DescriptionMI-538 is an interaction between menin and MLL fusion proteins inhibitor(IC50 of 21 nM).
In vitroTreatment with MI-538 results in strong down regulation of expression of Hoxa9 and Meis1 genes. About 100 nM 27 was sufficient to reduce by ~50% Hoxa9 expression in MLL-AF9 cells, and even more pronounced effect was seen on Meis1 expression.
In vivoTreatment with MI-538 leads to an approximately 80% reduction in MV4;11 tumor volume, with minimal toxicity, evidenced by less than a 10% decrease in body weight.
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (17.65 mM), Sonication is recommended.
DMSO : 95 mg/mL (167.67 mM), Sonication is recommended.
KeywordsMI-538 | MI538 | MI 538 | Menin-MLL | menin and MLL interaction | menin | Inhibitor | inhibit | HistoneMethyltransferase | Histone Methyltransferase | EpigeneticReaderDomain | Epigenetic Reader Domain
Inhibitors RelatedMAK-683 hydrochloride | ABBV-744 | 3-methyl-1,2,3,4-tetrahydroquinazolin-2-one | Tazemetostat | Piribedil | 5-Ph-IAA | Curcumin | EPZ015666 | iso-Azalansta | Naphthol AS-E | MRTX-1719 | JQ-1 (carboxylic acid)
Related Compound LibrariesReprogramming Compound Library | Histone Modification Compound Library | Methylation Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Epigenetics Compound Library | Chromatin Modification Compound Library | Inhibitor Library | PPI Inhibitor Library | Bioactive Compounds Library Max | Fluorochemical Library | Anti-Cancer Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$1460.00
VIP2Y
TargetMol Chemicals Inc.
2026-07-15
$123.00
VIP4Y
TargetMol Chemicals Inc.
2026-07-14
Hubei Chuchang Biotech Co., Ltd.
2025-03-16

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY
唐海县| 舒城县| 从化市| 图木舒克市| 娄底市| 浠水县| 永顺县| 北安市| 章丘市| 山东省| 个旧市| 盐城市| 顺平县| 绿春县| 台东市| 芒康县| 凤翔县| 石渠县| 南通市| 子洲县| 阳原县| 徐闻县| 高邮市| 台前县| 石泉县| 胶州市| 名山县| 阜新市| 恩施市| 老河口市| 肃宁县| 尼木县| 广安市| 隆尧县| 称多县| 麟游县| 定西市| 丰顺县| 化德县| 天台县| 辉县市|